Atenolol NDC 68788-8834

Product information

Brand name (proprietary)

Atenolol

Generic name (nonproprietary)

atenolol

Active ingredients

Atenolol — 50 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Preferred Pharmaceuticals Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 078512

Marketing start

Feb 21, 2025

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 68788-8834_0f744371-94fa-419d-bfed-b22301dde8b8SPL ID 0f744371-94fa-419d-bfed-b22301dde8b8SPL set ID 0f744371-94fa-419d-bfed-b22301dde8b8RxCUI 197381UNII 50VV3VW0TI

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788883401 followed by a unit qualifier and the quantity Copy

Package 68788-8834-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 078512

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.